CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MERCK

MRK
$364.35BMega Cap

Next catalyst

PDUFAApr 22, 2027in 155 days

IDVYNSO

HIV-1 infection in certain virologically suppressed adults

Get an email about MRK's next catalysts

Track MERCK (MRK) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 60 more upcoming events in our data (Phase 2 readout, Phase 3 readout, PDUFA date).See the timeline

Catalyst Timeline

64 upcoming, 9 past

Phase 2

Axatilimab Phase 2 Est. Readout

December 2026~Axatilimab35

Estimated primary completion for Axatilimab trial (NCT05491226) in TNBC - Triple-Negative Breast Cancer. Topline data typically follows completion by weeks to months.

Source
Phase 2

Pembrolizumab Phase 2 Est. Readout

December 2026~pembrolizumab37

Estimated primary completion for Pembrolizumab trial (NCT04421560) in Primary Central Nervous System Lymphoma. Topline data typically follows completion by weeks to months.

Source
Phase 2

pembrolizumab Phase 2 Est. Readout

December 2026~pembrolizumab372

Estimated primary completion for pembrolizumab trial (NCT04879329) in Urothelial Carcinoma. Topline data typically follows completion by weeks to months.

Source
Phase 2
✓Positive

TU2218 + KEYTRUDA® (Pembrolizumab) Phase 2 Est. Readout

December 2026~TU2218 + KEYTRUDA® (Pembrolizumab)140

Estimated primary completion for TU2218 + KEYTRUDA® (Pembrolizumab) trial (NCT05784688) in Solid Tumor. Topline data typically follows completion by weeks to months.

Zero cancer recurrence in 32 patients after nearly three years of follow-up with neoadjuvant pembrolizumab before surgery

Source
Phase 2

Infliximab Phase 2 Est. Readout (RAPID-I)

December 2026~Infliximab240

Estimated primary completion for Infliximab trial (NCT03684278) in Acute Pancreatitis. Topline data typically follows completion by weeks to months.

Source
Phase 2

Pembrolizumab Phase 2 Est. Readout

December 2026~pembrolizumab25

Estimated primary completion for Pembrolizumab trial (NCT05756569) in Bladder Squamous Cell Carcinoma. Topline data typically follows completion by weeks to months.

Source
Phase 2

Belzutifan Phase 2 Est. Readout

December 2026~Belzutifan60

Estimated primary completion for Belzutifan trial (NCT05468697) in Renal Cell Carcinoma. Topline data typically follows completion by weeks to months.

Source
Phase 2

Lenvatinib Phase 2 Est. Readout

December 2026~Lenvatinib40

Estimated primary completion for Lenvatinib trial (NCT05147558) in Uterine Carcinosarcoma. Topline data typically follows completion by weeks to months.

Source

Upcoming FDA decisions

How MRK's past catalysts played out

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsPharmaceuticals🇺🇸North AmericaRAHWAY75.0K employees

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.

Website
Drug Pipeline

KEYTRUDA®

Approved

Cervical Cancer

ANV600 + pembrolizumab (KEYTRUDA®)

Approved

Advanced Solid Tumor

TU2218 + KEYTRUDA® (Pembrolizumab)

Approved

Solid Tumor

Glipizide

Phase 3

Diabetes Mellitus, Type 2

Cladribine Low Dose

Phase 3

Generalized Myasthenia Gravis

Colistimethate sodium (CMS)

Phase 3

Bacterial Infections

Acarbose

Phase 3

Type 2 Diabetes Mellitus

Rebif® New Formulation (IFN-beta-1a, RNF)

Phase 3

Multiple Sclerosis, Relapsing-Remitting

Patritumab Deruxtecan

Phase 3

Malignant Neoplasm

M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX®

Phase 3

Measles

regorafenib

Phase 3

Colorectal Cancer

Fluorouracil (5-FU)

Phase 3

Urinary Bladder Neoplasms

Elbasvir/Grazoprevir Fixed Dose Combination

Phase 3

Chronic HCV Infection

Rizatriptan co-administered with Acetaminophen

Phase 3

Migraine

Peginterferon alfa-2b (PEG)

Phase 3

Hepatitis C, Chronic

sitagliptin phosphate (+) metformin hydrochloride

Phase 3

Type 2 Diabetes Mellitus

Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine

Phase 3

HPV Infections

2XP HEPTAVAX™-II SC

Phase 3

Hepatitis B

Ribavirin (SCH 18908)

Phase 3

Hepatitis C, Chronic

V110, pneumococcal vaccine polyvalent

Phase 3

Healthy

montelukast sodium

Phase 3

Asthma

R-DXD

Phase 3

Lung Neoplasm

Rocuronium bromide (Zemuron)

Phase 3

Anesthesia

Gardasil

Phase 3

Papillomavirus Infections

Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine

Phase 3

Cervical Cancer

ART

Phase 3

HIV-1 Infection

Pegylated interferon alfa-2b (PegIntron)

Phase 3

Hepatitis B, Chronic (CHB)

Sitagliptin plus metformin

Phase 3

Type 2 Diabetes Mellitus

DOR

Phase 3

HIV-1 Infection

M-M-R®II

Phase 3

Pneumococcal Infections

Linezolid

Phase 3

Pneumonia

liposomal doxorubicin

Phase 3

Breast Neoplasms

diquafosol tetrasodium (INS365) ophthalmic solution

Phase 3

Dry Eye Disease

denufosol tetrasodium (INS37217) Inhalation Solution

Phase 3

Cystic Fibrosis

succinylcholine

Phase 3

Neuromuscular Blockade

Intismeran

Phase 3

Non-small Cell Lung Cancer

MK-1084

Phase 3

Colon Adenocarcinoma

AzaSite

Phase 3

Bacterial Conjunctivitis

rosiglitazone

Phase 3

Type 2 Diabetes Mellitus

Cyclophosphamide

Phase 3

Metastatic Breast Cancer

VARIVAX™ New Seed Process

Phase 3

Varicella

peg-IFN

Phase 3

Hepatitis C, Chronic

Sofosbuvir

Phase 3

Hepatitis C

Pneumococcal Vaccine, Polyvalent (23-valent)

Phase 3

Pneumococcal Infection

Reformulated Raltegravir

Phase 3

HIV Infection

Ribavirin (RBV)

Phase 3

Hepatitis C, Chronic

simvastatin/ezetimibe

Phase 3

Hyperlipidemia

Cetrorelix acetate

Phase 3

Polycystic Ovarian Syndrome

REBETOL (ribavirin; SCH 18908)

Phase 3

Hepatitis C, Chronic

Background PAH Therapy

Phase 3

Pulmonary Arterial Hypertension

RotaTeq™ - Rotavirus Vaccine, Live, Oral, Pentavalent

Phase 3

Vomiting

levoleucovorin

Phase 3

Esophageal Squamous Cell Carcinoma (ESCC)

losartan potassium + hydrochlorothiazide + amlodipine besylate (MK-0954E)

Phase 3

Hypertension

V503 Vaccine

Phase 3

Papillomavirus Infections

boceprevir (SCH 503034)

Phase 3

Chronic Hepatitis C

V110

Phase 3

Pneumococcal Infection

Tivantinib

Phase 3

Advanced Solid Tumors

Cetuximab plus Platinum-based Doublet Chemotherapy

Phase 3

Non-Small Cell Lung Cancer (NSCLC)

Saizen® A

Phase 3

Children Born With Serious Intra-uterine Growth Retardation

vinflunine

Phase 3

Urothelial Cancer

MK-0524B

Phase 3

Primary Hypercholesterolemia

Sevoflurane

Phase 3

Muscle Relaxation

LdT (Telbivudine) and lamivudine

Phase 3

Hepatitis B

BIC/FTC/TAF

Phase 3

HIV-1 Infection

lovastatin

Phase 3

Atherosclerosis

L-PZQ ODT

Phase 3

Schistosomiasis

daptomycin

Phase 3

Pneumonia, Bacterial

Tenofovir + lamivudine + raltegravir

Phase 3

HIV-1 Infection

MK-8748

Phase 3

Diabetic Retinopathy

HIBERIX™

Phase 3

Pneumococcal Infections

MMRV (AMP)

Phase 3

Measles

Folinic Acid

Phase 3

Metastatic Colorectal Cancer

Lamivudine

Phase 3

HIV Infections

RotaTeq™ experimental formulation

Phase 3

Rotavirus Gastroenteritis

Modified Process Hepatitis B Vaccine

Phase 3

Hepatitis B

Ifinatamab Deruxtecan

Phase 3

Castration-Resistant Prostatic Cancer

MK0557

Phase 3

Obesity

Bomedemstat

Phase 3

Thrombocythemia, Essential

Sulfonylurea

Phase 3

Type 2 Diabetes Mellitus

Pembrolizumab (MK-3475)

Phase 3

Merkel Cell Carcinoma

Zidovudine

Phase 3

HIV Infections

MK-0518

Phase 3

HIV Infections

alvimopan

Phase 3

Ileus

Kuvan®

Phase 3

Phenylketonuria

Tulisokibart

Phase 3

Hidradenitis Suppurativa

luspatercept

Phase 3

B-Thalassemia

Pioglitazone hydrochloride

Phase 3

Type 2 Diabetes Mellitus

BCG

Phase 3

Urinary Bladder Neoplasms

Rebif®

Phase 3

Clinically Isolated Syndrome

Zoster Vaccine, Live (Oka-Merck)

Phase 3

Varicella Virus Infection

Nemtabrutinib

Phase 3

Chronic Lymphocytic Leukemia

Grazoprevir/Elbasvir fixed-dose combination

Phase 3

Chronic Hepatitis C

Zoster Vaccine, Live (Oka-Merck), ZOSTAVAX™

Phase 3

Herpes Zoster

Prevnar 13®

Phase 3

Streptococcus Pneumoniae Infection

Pembrolizumab Formulated with Berahyaluronidase Alfa

Phase 3

Metastatic Non-small Cell Lung Cancer

Extended-release niacin (ERN)

Phase 3

Dyslipidemia

Prevnar 13™

Phase 3

Pneumococcal Infections

Pneumovax™ 23

Phase 3

Pneumococcal Infections

MK0831

Phase 3

HIV Infections

RotaTeq (V260)

Phase 3

Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9

Preservative-Free Tafluprost

Phase 3

Open-angle Glaucoma

Palivizumab

Phase 3

RSV Infection

Posaconazole

Phase 3

Mycoses

Rotateq™

Phase 3

Rotavirus Infections

Clesrovimab

Phase 3

Respiratory Syncytial Viruses

ProQuad (Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live)

Phase 3

Measles

Metformin - Rescue

Phase 3

Diabetes Mellitus, Type 2

Filgrastim

Phase 3

Metastatic Non-small Cell Lung Cancer

Infanrix® hexa

Phase 3

Varicella

granisetron

Phase 3

Chemotherapy-induced Nausea and Vomiting (CINV)

MK-8527

Phase 3

Human Immunodeficiency Virus (HIV)

PCV15 - Part B

Phase 3

Pneumococcal Disease

Zoster Vaccine, Live (Zostavax™)

Phase 3

Shingles

Zilovertamab vedotin

Phase 3

B-cell Acute Lymphoblastic Leukemia

Doravirine, Tenofovir, Lamivudine

Phase 3

HIV-1 Infection

Pembrolizumab/Quavonlimab

Phase 3

Colorectal Cancer

MK-5172A

Phase 3

Chronic Hepatitis C

PegIntron (peginterferon alfa-2b; SCH 54031)

Phase 3

Hepatitis

Grazoprevir

Phase 3

Chronic Hepatitis C (CHC)

IV Tulisokibart

Phase 3

Crohn's Disease

PEG-Intron

Phase 3

Hepatitis C

Granulocyte Colony-Stimulating Factor (G-CSF)

Phase 3

DLBCL

MK0217, alendronate sodium

Phase 3

Osteoporosis

DOR/ISL

Phase 3

HIV Infection

Emtricitabine/tenofovir disoproxil (FTC/TDF)

Phase 3

Human Immunodeficiency Virus (HIV)

Zoster Vaccine, Live

Phase 3

Herpes Zoster

Efprezimod alfa

Phase 3

Graft Versus Host Disease

Zoster Vaccine, Live (AMP)

Phase 3

Herpes Zoster

Gonalef® (Follitropin alfa)

Phase 3

Infertility

Cisplatin/Carboplatin

Phase 3

Carcinoma, Squamous Cell of Head and Neck

Rocuronium bromide (Org 9426)

Phase 3

Muscle Relaxation

Naproxen

Phase 3

Endometriosis-related Pain

ProQuad® manufactured with recombinant Human Albumin (rHA)

Phase 3

Measles

Gardasil™

Phase 3

Papillomavirus Infections

Varicella Virus Vaccine Live (Oka-Merck)

Phase 3

Varicella

Fosaprepitant dimeglumine

Phase 3

Chemotherapy-Induced Nausea and Vomiting (CINV)

V181

Phase 3

Healthy

Human Papillomavirus (HPV) 16 Monovalent

Phase 3

Cervical Cancer

PegIntron

Phase 3

Hepatitis C

Atropine

Phase 3

Anesthesia, General

Glycemic Rescue 1

Phase 3

Diabetes Mellitus

RECOMBIVAX HB™

Phase 3

Pneumococcal Infections

Sitagliptin + Pioglitazone

Phase 3

Type 2 Diabetes Mellitus

Axitinib

Phase 3

Renal Cell Carcinoma

fidaxomicin

Phase 3

Clostridium Difficile-Associated Diarrhea (CDAD)

Rocuronium intubating

Phase 3

Anesthesia

Androgen Deprivation Therapy (ADT)

Phase 3

Metastatic Hormone-Sensitive Prostate Cancer

Rocuronium bolus maintenance

Phase 3

Anesthesia

Glimerpiride

Phase 3

Type 2 Diabetes Mellitus

losartan potassium

Phase 3

Hypertension

anacetrapib

Phase 3

Coronary Heart Disease (CHD)

MK0524A

Phase 3

Flushing

V114

Phase 3

Pneumococcal Infections

Cisplatin (as radiosensitizer)

Phase 3

Endometrial Neoplasms

Vecuronium

Phase 3

Anesthesia, General

Suvorexant Low Dose (LD)

Phase 3

Primary Insomnia

Peginterferon alfa-2b (PEG2b)

Phase 3

Hepatitis C, Chronic

sitagliptin phosphate

Phase 3

Type 2 Diabetes

Peg-interferon alfa-2b

Phase 3

Hepatitis C, Chronic

dorzolamide hydrochloride (+) timolol maleate

Phase 3

Glaucoma

peg-Interferon alfa-2a

Phase 3

Hepatitis C, Chronic

Calderasib

Phase 3

Non-small Cell Lung Cancer

ZOSTAVAX

Phase 3

Herpes Zoster

Relebactam

Phase 3

Intra-abdominal Infections

Infliximab

Phase 3

Psoriasis

(Gardasil™) human papillomavirus (types 6, 11, 16, 18) recombinant vaccine

Phase 3

Condylomata Acuminata

rofecoxib

Phase 3

Prostate Cancer

Peginterferon

Phase 3

Multiple Myeloma

M-M-R II™

Phase 3

Varicella

Oral Switch

Phase 3

Suspected or Documented Gram-negative Bacterial Infection

H2 Receptor Antagonist

Phase 3

Non-small Cell Lung Cancer (NSCLC)

RotaTeq®

Phase 3

Meningitis, Meningococcal

ProQuad®

Phase 3

Measles

MK0991, caspofungin acetate/Duration of Treatment

Phase 3

Fungal Infection

Sitagliptin/simvastatin FDC

Phase 3

Type 2 Diabetes Mellitus

Pre-treatment with rLH (Luveris)

Phase 3

Infertility, Female

Cilastatin

Phase 3

Bacterial Pneumonia

Pegylated filgrastim

Phase 3

Metastatic Non-small Cell Lung Cancer

IV golimumab

Phase 3

Arthritis, Rheumatoid

RotaTeq™, rotavirus vaccine, live, oral, pentavalent

Phase 3

Rotavirus Infections

Quadrivalent Human Papillomavirus (HPV, Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®)

Phase 3

Papillomavirus Infections

Boceprevir (BOC)

Phase 3

Chronic Hepatitis C

Intismeran autogene

Phase 3

Bladder Cancer

MK0869, aprepitant

Phase 3

Postoperative Nausea and Vomiting

Infliximab + methotrexate (IFX + MTX)

Phase 3

Arthritis, Psoriatic

Rebif New Formulation + prophylactic Ibuprofen

Phase 3

Relapsing Multiple Sclerosis

Metformin IR

Phase 3

Type 2 Diabetes Mellitus

Pembrolizumab/Vibostolimab Co-Formulation

Phase 3

Small Cell Lung Carcinoma

Voriconazole

Phase 3

Aspergillosis

Short ragweed pollen allergen extract

Phase 3

Rhinitis, Allergic, Seasonal

MK0803, lovastatin

Phase 3

Hypercholesterolemia

Aprepitant

Phase 3

Post-operative Nausea

MK-3475A

Phase 3

Non-small Cell Lung Cancer

PPSV23

Phase 3

Pneumococcal Disease

Trifluridine-Tipiracil

Phase 3

Gastroesophageal Cancer

Rescue medication

Phase 3

Non-Muscle Invasive Bladder Cancer

Tisotumab Vedotin

Phase 3

Cervical Cancer

Pembrolizumab (K)

Phase 3

Breast Cancer

Zoster Vaccine Live

Phase 3

Herpes Zoster

niacin (+) laropiprant

Phase 3

Hypercholesterolemia

TAS-102 (trifluridine and tipiracil)

Phase 3

Colorectal Neoplasms

favezelimab/pembrolizumab

Phase 3

Hodgkin Lymphoma

Golimumab

Phase 3

Spondylitis, Ankylosing

zoster vaccine live (ZOSTAVAX™)

Phase 3

Herpes Zoster

Diquafosol tetrasodium ophthalmic

Phase 3

Dry Eye Disease

Granulocyte colony stimulating factor: Filgrastim or Pegfilgrastim

Phase 3

Triple Negative Breast Neoplasms

TAS-102

Phase 3

Colorectal Cancer

Infliximab + methotrexate (MTX)

Phase 3

Arthritis, Rheumatoid

Montelukast

Phase 3

Asthma

Boceprevir

Phase 3

Chronic Hepatitis C Genotype 1

Ensifentrine

Phase 3

COPD

Epirubicin

Phase 3

Triple Negative Breast Neoplasms

Enlicitide

Phase 3

Hyperlipidemia

Esmirtazapine

Phase 3

Insomnia

Pergoveris®

Phase 3

Infertility

Meropenem

Phase 3

Healthcare-Associated Pneumonia

ER niacin/laropiprant

Phase 3

Diabetes Mellitus Type 2

PNEUMOVAX™23

Phase 3

Pneumococcal Infections

Enalapril

Phase 3

Hypertension

Tedizolid phosphate

Phase 3

Acute Bacterial Skin and Skin Structure Infections

r-hCG

Phase 3

Infertility

Ceftolozane/Tazobactam

Phase 3

Complicated Intra-Abdominal Infection

hMG

Phase 3

Infertility

Cetuximab + Platinum (Cisplatin or Carboplatin) + 5Fluorouracil (5-FU)

Phase 3

Head and Neck Cancer

Grazoprevir + Elbasvir

Phase 3

Hepatitis C Infection

Cetuximab + concomitant boost radiotherapy

Phase 3

Squamous Cell Carcinoma of the Head and Neck

SC golimumab

Phase 3

Arthritis, Rheumatoid

Voglibose

Phase 3

Diabetes Mellitus, Non-Insulin-Dependent

ER-niacin

Phase 3

Primary Hypercholesterolaemia

MK-1293

Phase 3

Type 1 Diabetes Mellitus

Bisoprolol/Amlodipine (Bisoprolol failed group)

Phase 3

Hypertension

PAR-101/OPT-80

Phase 3

Clostridium Infections

ZOSTAVAX™

Phase 3

Herpes Zoster

cetuximab + cisplatin + vinorelbine

Phase 3

Non Small Cell Lung Cancer (NSCLC)

Ertapenem sodium

Phase 3

Infection; Diabetic Foot

sitagliptin/metformin ≥

Phase 3

Type 2 Diabetes Mellitus (T2DM)

ER niacin (+) laropiprant (ERN/LRPT)

Phase 3

Dyslipidemia

MK0966

Phase 3

Pain, Postoperative Arthroscopy

MK0966; Rofecoxib

Phase 3

Colorectal Adenoma

Decadron

Phase 3

Malignant Neoplasms of Male Genital Organs

L50/H12.5/A5

Phase 3

Hypertension

Frespaciguat

Phase 3

Pulmonary Hypertension

MK0826

Phase 3

Complicated Intra-Abdominal Infections

sugammadex

Phase 3

Neuromuscular Blockade

pneumococcal 23v polysaccharide vaccine

Phase 3

Pneumococcal Infection

niacin (+) laropiprant (+) simvastatin

Phase 3

Primary Hypercholesterolemia

Modified Process Hepatitis B Vaccine (Experimental)

Phase 3

Hepatitis B

Pembrolizumab/Vibostolimab

Phase 3

Lung Neoplasms

Tedizolid Phophate

Phase 3

Skin Diseases, Infectious

MK0507A, dorzolamide hydrochloride (+) timolol maleate

Phase 3

Glaucoma

Finasteride

Phase 3

Enlarged Prostate

raltegravir

Phase 3

HIV

Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL™)

Phase 3

Papillomavirus Infections

V212

Phase 3

Herpes Zoster

raltegravir potassium

Phase 3

HIV Infections

rotavirus vaccine, live, oral, pentavalent

Phase 3

Rotavirus Infections

Combination of pegylated interferon alfa-2b and ribavirin

Phase 3

Hepatitis C, Chronic

Dexamethasone

Phase 3

Non-Small-Cell Lung Carcinoma

Measles, Mumps, and Rubella Virus Vaccine Live (MMR)

Phase 3

Varicella

Grazoprevir/Elbasvir

Phase 3

Hepatitis C

MK0217A, alendronate sodium (+) cholecalciferol

Phase 3

Osteoporosis

hydrochlorothiazide (HCTZ)

Phase 3

Hypertension

pembrolizumab

Phase 3

Colorectal Neoplasms

Open-label Metformin

Phase 3

Type 2 Diabetes

loratadine; montelukast

Phase 3

Rhinitis, Allergic, Seasonal

Recombinant Human Papillomavirus Nonavalent Vaccine

Phase 3

AIDS-Related Human Papillomavirus Infection

caspofungin acetate

Phase 3

Fungal Infection

Isentress®

Phase 3

HIV Infections

Acid Nicotinique

Phase 3

Acute Coronary Syndrome (ACS)

laropiprant/niacin (MK0524A)

Phase 3

Hypercholesterolemia

Sitagliptin

Phase 3

Hyperlipidemia

9vHPV vaccine

Phase 3

Papillomavirus Infections

2XP HEPTAVAX™-II IM

Phase 3

Hepatitis B

Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live

Phase 3

Measles

Olaparib

Phase 3

Ovarian Cancer

Mitomycin C (MMC)

Phase 3

Urinary Bladder Neoplasms

Lantus™

Phase 3

Type 2 Diabetes Mellitus

Gonal-f®

Phase 3

Assisted Reproductive Techniques

IPV

Phase 3

Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9

FTC/TDF + EFV or LPV/R +T20

Phase 3

HIV Infections

Human Chorionic Gonadotropin (hCG)

Phase 3

Luteal Hormone Supplementation in In-vitro Fertilization

Ropeginterferon alfa-2b

Phase 3

Polycythemia Vera

7-valent pneumococcal-CRM197 conjugate vaccine

Phase 3

Otitis Media

COL-1620

Phase 3

Luteal Hormone Supplementation in In-vitro Fertilization

V441, diptheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant), & Haemophilus influenza type b conjugate vaccine

Phase 3

Diphtheria

Stavudine

Phase 3

HIV Infections

Glycemic Rescue

Phase 3

Type 2 Diabetes Mellitus

Raptiva

Phase 3

Moderate to Severe Psoriasis

M-M-R II®

Phase 3

Varicella

mRNA-1273 Vaccine

Phase 3

Papillomavirus Infections

V501

Phase 3

Human

Rescue Medications

Phase 3

Cervical Cancer

MTX

Phase 3

Arthritis, Rheumatoid

Vancomycin (or equivalent)

Phase 3

Acute Hematogenous Osteomyelitis

Insulin

Phase 3

Type 2 Diabetes Mellitus

Ezetimibe

Phase 3

Hypercholesterolemia

Preladenant

Phase 3

Parkinson Disease

Calcium supplement

Phase 3

Osteoporosis

oral contraceptive pill pretreatment (Marvelon)

Phase 3

Infertility, Female

V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine

Phase 3

Cervical Cancer

V920 Consistency Lot A

Phase 3

Prevention of Ebola Infection

Peginterferon alfa-2a

Phase 3

Hepatitis C, Chronic

sitagliptin/metformin

Phase 3

Type 2 Diabetes Mellitus

Letermovir

Phase 3

Cytomegalovirus Infection

Opevesostat

Phase 3

Prostate Cancer Metastatic

Sotatercept

Phase 3

Pulmonary Arterial Hypertension

Bezlotoxumab

Phase 3

Clostridium Difficile Infection

V232 Modified Process Hepatitis B Vaccine: Lot A

Phase 3

Hepatitis B Infection

Riociguat (Adempas, BAY63-2521)

Phase 3

Hypertension, Pulmonary

PCV20

Phase 3

Pneumococcal Infection

PCV13

Phase 3

Pneumococcal Infections

Pentacel™

Phase 3

Pneumococcal Infections

losartan potassium (+) hydrochlorothiazide

Phase 3

Hypertension

V260

Phase 3

Rotavirus Gastroenteritis

Varicella Virus Vaccine Live (2007 Process) (Oka/Merck)

Phase 3

Varicella

Prednisone

Phase 3

Prostate Cancer Aggressiveness

Ezetimibe/Simvastatin

Phase 3

Type 1 Diabetes Mellitus

ISL/ULO

Phase 3

Human Immunodeficiency Virus Type 1 (HIV-1) Infection

Ertugliflozin

Phase 3

Type 2 Diabetes Mellitus

Interferon-alpha2b - 1 year

Phase 3

Melanoma

Varicella-zoster vaccine

Phase 3

Herpes Zoster

Cladribine (MAVENCLAD®)

Phase 3

Advanced Multiple Sclerosis

Tobramycin

Phase 3

Bacterial Conjunctivitis

Pegylated interferon alfa-2b

Phase 3

Hepatitis C

Peginterferon alfa-2b

Phase 3

Carcinoma, Hepatocellular

Ipragliflozin

Phase 3

Type 2 Diabetes Mellitus

Rocuronium bromide

Phase 3

Anesthesia

IMI/REL

Phase 3

Suspected or Documented Gram-negative Bacterial Infection

MK0966, rofecoxib

Phase 3

Postoperative Pain

Basal Insulin

Phase 3

Type 2 Diabetes Mellitus

Posaconazole oral suspension

Phase 3

Mycoses

sac-TMT

Phase 3

Non-small Cell Lung Cancer

Grazoprevir/Elbasvir FDC tablet (MK-5172A)

Phase 3

Chronic Hepatitis C

Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin

Phase 3

Hepatitis C, Chronic

Org 50081

Phase 3

Insomnia

budesonide and montelukast

Phase 3

Obstructive Sleep Apnea

Avonex®

Phase 3

Multiple Sclerosis, Relapsing-Remitting

Corifollitropin Alfa

Phase 3

Infertility, Female

Follitropin alfa liquid formulation

Phase 3

Infertility

Metronidazole

Phase 3

Complicated Intra-abdominal Infections

Ritonavir

Phase 3

HIV Infections

Vericiguat tablet

Phase 3

Heart Failure

Micronised Progesterone

Phase 3

Infertility

HBVAXPRO™

Phase 3

Hepatitis B

Paclitaxel

Phase 3

Non-small Cell Lung Cancer

VARIVAX™

Phase 3

Varicella

Levocarnitine

Phase 3

HIV Infections

SC Tulisokibart

Phase 3

Ulcerative Colitis

Imipenem+Cilastatin/Relebactam

Phase 3

Complicated Intra-abdominal Infection

Etoricoxib

Phase 3

Knee Osteoarthritis

MK0826, ertapenem sodium

Phase 3

Infections

Elbasvir

Phase 3

Hepatitis C

Vericiguat

Phase 3

Heart Failure

Doravirine

Phase 3

HIV-1

DAPTACEL™

Phase 3

Bacterial Infections

Telcagepant

Phase 3

Migraine

Pembrolizumab (+) Berahyaluronidase alfa

Phase 3

Lung Cancer

Fidaxomicin tablets

Phase 3

Clostridium Difficile-associated Diarrhea (CDAD)

IMI/REL FDC

Phase 3

Hospital-Acquired Bacterial Pneumonia

MMR II™

Phase 3

Pneumococcal Infections

Zanzalintinib

Phase 3

Renal Cell Carcinoma

Gardasill 9™ vaccine

Phase 3

Neoplasia

MK0974

Phase 3

Migraine

sitagliptin/pioglitazone q.d

Phase 3

Type 2 Diabetes Mellitus

Lenvatinib

Phase 3

Non-small Cell Lung Cancer

raltegravir (Isentress)

Phase 3

HIV Infections

week 24

Phase 3

Peripheral Spondyloarthritis

Fludrocortisone acetate

Phase 3

Prostate Cancer Metastatic

V503 (9-valent Human Papillomavirus L1 Virus-Like Particle vaccine)

Phase 3

Human Papillomavirus Infection

V116

Phase 3

Pneumococcal Infection

Omarigliptin

Phase 3

Type 2 Diabetes Mellitus

Vicriviroc

Phase 3

HIV Infections

Molnupiravir

Phase 3

Coronavirus Disease (COVID-19)

MR Prednisone

Phase 3

Rheumatoid Arthritis

ertapenem sodium (MK0826)

Phase 3

Urinary Tract Infection

Pegylated liposomal doxorubicin (SCH 200746)

Phase 3

Breast Cancer

VAQTA™

Phase 3

Pneumococcal Infections

peginterferon alfa-2b (SCH 54031)

Phase 3

Chronic Hepatitis C

Pembrolizumab SC

Phase 3

Non-Small Cell Lung Cancer

9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)

Phase 3

HPV Positive Oropharyngeal Squamous Cell Carcinoma

ISL

Phase 3

Human Immunodeficiency Virus Type 1 (HIV-1) Infection

MK-6072

Phase 3

Clostridium Difficile Infection

TR-701 FA

Phase 3

Skin and Subcutaneous Tissue Bacterial Infections

sodium chloride (NaCl)

Phase 3

Anesthesia

Combination of (a) pegylated interferon alfa-2b and (b) rebetol

Phase 3

Liver Transplantation

Pegylated interferon alfa-2b (SCH 54031)

Phase 3

Hepatitis C, Chronic

Neostigmine

Phase 3

Anesthesia

5-Fluorouracil

Phase 3

Uterine Cervical Neoplasms

CB-183,315

Phase 3

Clostridium Difficile Infection

INFANRIX™ hexa

Phase 3

Bacterial Infections

PR5I

Phase 3

Neisseria Meningitidis

Gefapixant

Phase 3

Chronic Cough

Gliclazide

Phase 3

Type 2 Diabetes Mellitus

ceftriaxone sodium

Phase 3

Infection

PCV15

Phase 3

Pneumonia, Pneumococcal

TRUVADA®

Phase 3

HIV Infections

eribulin

Phase 3

Metastatic Triple Negative Breast Cancer

Indinavir sulfate

Phase 3

HIV Infections

Delstrigo

Phase 3

HIV-1-infection

ezetimibe with simvastatin

Phase 3

Hypercholesterolemia

Ridaforolimus

Phase 3

Sarcoma

V503

Phase 3

Papillomavirus Infections

MK-0524A

Phase 3

Hypercholesteremia

Saizen®

Phase 3

Fibromyalgia

Supportive care measures

Phase 3

Non-small Cell Lung Cancer (NSCLC)

Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live

Phase 3

Measles

Recombinant human luteinizing hormone (r-hLH)

Phase 3

Hypogonadism

mFOLFOX6

Phase 3

Colorectal Carcinoma

alendronate with cholecalciferol

Phase 3

Osteoporosis

Sitagliptin (MK0431)

Phase 3

Diabetes Mellitus, Type II

Ezetimibe + Atorvastatin

Phase 3

Hypercholesterolemia

Efavirenz

Phase 3

HIV Infections

V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine/Duration of Treatment: 4 years

Phase 3

Cervical Cancer

Peginterferon alfa-2b (PegIntron, SCH 54031)

Phase 3

Hepatitis D, Chronic

RNF

Phase 3

Multiple Sclerosis

ezetimibe (plus simvastatin)

Phase 3

Atherosclerosis

H1 receptor antagonist

Phase 3

Ovarian Cancer

Telcagepant potassium

Phase 3

Migraine

Epacadostat

Phase 3

Gastric Adenocarcinoma

Cisplatin

Phase 3

Head and Neck Neoplasms

Hepatitis A Vaccine, Purified Inactivated (VAQTA™)

Phase 3

Hepatitis A Virus Infection

Enlicitide Decanoate

Phase 3

Hypercholesterolemia

Odanacatib

Phase 3

Osteoporosis Postmenopausal

pegylated interferon alpha-2b

Phase 3

Hepatitis B, Chronic

Rotavirus vaccine

Phase 3

Bacterial Infections

MK-8591A

Phase 3

HIV-1 Infection

Estrogens

Phase 3

Infertility

Interferon-beta-1a

Phase 3

Hepatitis C

Dinaciclib

Phase 3

Chronic Lymphocytic Leukemia (CLL)

Acetaminophen (or equivalent)

Phase 3

Non-small Cell Lung Cancer (NSCLC)

V419

Phase 3

Bacterial Infections

Suvorexant

Phase 3

Insomnia

Dexamethasone (or equivalent)

Phase 3

Non-small Cell Lung Cancer (NSCLC)

ATRIPLA™

Phase 3

Human Immunodeficiency Virus (HIV)

MK-1045

Phase 3

Lymphoma, Non-Hodgkin

Rocuronium maintenance

Phase 3

Anesthesia

Rocuronium

Phase 3

Anesthesia, General

vaniprevir

Phase 3

Hepatitis C, Chronic

Blinatumomab

Phase 3

B-cell Acute Lymphoblastic Leukemia

Anagrelide

Phase 3

Essential Thrombocythemia

Steroid Mouthwash (dexamethasone or equivalent)

Phase 3

Non-small Cell Lung Cancer (NSCLC)

ULO

Phase 3

Human Immunodeficiency Virus Type 1 (HIV-1) Infection

ZOSTAVAX™ (concomitant)

Phase 3

Herpes Zoster

Enpatoran

Phase 3

Systemic Lupus Erythematosus (SLE)

CXA-201

Phase 3

Complicated Urinary Tract Infection

Telcagepant soft

Phase 3

Migraine

VARIVAX® PE34 Process

Phase 3

Varicella

Rotarix™

Phase 3

Pneumococcal Infections

Vorinostat

Phase 3

Mesothelioma

Vericiguat suspension

Phase 3

Heart Failure

KOCITAF

Phase 3

HIV-1-infection

M-M-R™ II

Phase 3

Pneumococcal Infections

MK-3415

Phase 3

Clostridium Difficile Infection

Belzutifan

Phase 3

Renal Cell Carcinoma

Clonidine

Phase 3

Malignant Neoplasms of Male Genital Organs

Lisinopril

Phase 3

Kidney, Polycystic

Leucovorin/levoleucovorin

Phase 3

Metastatic Colorectal Cancer

Rocurium

Phase 3

Anesthesia, General

Surotomycin

Phase 3

Clostridium Difficile Infection

neostigmine and glycopyrrolate or atropine

Phase 3

Neuromuscular Blockade

rolofylline

Phase 3

Heart Failure, Congestive

Epinephrine

Phase 3

Malignant Neoplasms of Male Genital Organs

epinastine nasal spray, low concentration, low dose volume

Phase 3

Seasonal Allergic Rhinitis

Simvastatin

Phase 3

Cardiovascular Disease

INS365 Ophthalmic Solution

Phase 3

Keratoconjunctivitis Sicca

QIV

Phase 3

Pneumonia, Pneumococcal

Letermovir tablet

Phase 3

Cytomegalovirus Infection

peginterferon alfa-2b (PEG2b) (SCH 54031)

Phase 3

Hepatitis C, Chronic

Prulifloxacin

Phase 3

Acute Gastroenteritis in Adult Travelers

Acetaminophen/Paracetamol

Phase 3

Migraine Disorders

clindamycin/ketoconazole vaginal ovule

Phase 3

Vaginosis, Bacterial

Prevenar 13™

Phase 3

Pneumococcal Infections

Efalizumab

Phase 3

Moderate to Severe Psoriasis

Suvorexant High Dose (HD)

Phase 3

Primary Insomnia

Alviompan

Phase 3

Bowel Dysfunction

FOLFIRI (5-Fluorouracil, Folinic acid, Irinotecan)

Phase 3

Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer

Valganciclovir

Phase 3

CMV Disease

taranabant

Phase 3

Smoking

MK-7625A (ceftolozane/tazobactam)

Phase 3

Intra-abdominal Infection

Uridine 5'-Triphosphate (UTP) Solution for Inhalation

Phase 3

Lung Cancer

Imipenem

Phase 3

Bacterial Pneumonia

S-1

Phase 3

Gastric Cancer

Glycopyrrolate

Phase 3

Surgical Procedures, Elective

Rotavirus Vaccine, Live, Oral, Pentavalent (V260, RotaTeq™)

Phase 3

Rotavirus

Vaxelis™

Phase 3

Pneumococcal Infections

V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live

Phase 3

Measles

V501, Gardasil, Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine/Duration of Treatment : 4 Years

Phase 3

Cervical Cancer

RSV-A Memphis 37b

Phase 2

Respiratory Syncytial Viruses

Lonafarnib

Phase 2

Breast Cancer

Pemetrexed Cisplatin

Phase 2

Non Small Cell Lung Cancer

EVX-01

Phase 2

Melanoma Stage IV

PembroRT

Phase 2

Non-small Cell Lung Cancer, NSCLC

Brexucabtagene autoleucel (other names: brexu-cel, Tecartus)

Phase 2

Recurrent Mantle Cell Lymphoma

MK1903

Phase 2

Dyslipidemia

MK-2206

Phase 2

PANCREAS

Peginterferon alfa-2a (Peg-IFN)

Phase 2

Hepatitis C, Chronic

ANV600

Phase 2

Advanced Solid Tumor

Pembrolizumab/Favezelimab

Phase 2

Colorectal Cancer

Pembrolizumab (for 30 minutes

Phase 2

Breast Cancer

Ritonavir-boosted protease inhibitor

Phase 2

HIV

Uprifosbuvir (+) Grazoprevir (+) Ruzasvir

Phase 2

Hepatitis C

denufosol tetrasodium Inhalation Solution

Phase 2

Cystic Fibrosis

CXA-101

Phase 2

Complicated Urinary Tract Infection

pegylated interferon

Phase 2

Chronic Hepatitis C

Multiple low dose cyclophosphamide

Phase 2

Multiple Myeloma

Azacitadine

Phase 2

Acute Myeloid Leukemia

Cisplatin (TP)

Phase 2

Squamous Cell Carcinoma of the Hypopharynx

pIL-12

Phase 2

Melanoma

LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER

Phase 2

Solid Tumor, Adult

LY3537982

Phase 2

Carcinoma, Non-Small-Cell Lung

Butantan - DV

Phase 2

Dengue

KVA12123 Plus Pembrolizumab - Dose Escalation

Phase 2

Cancer

KVA12123 Plus Pembrolizumab - Dose Expansion

Phase 2

Cancer

denufosol tetrasodium (INS37217)

Phase 2

Cystic Fibrosis

OPT-80

Phase 2

Diarrhea

Dalotuzumab

Phase 2

Carcinoma, Non-small-cell Lung

MK-8777

Phase 2

Depression

KVA12123 - Dose Expansion

Phase 2

Cancer

ARQ 197

Phase 2

Pancreatic Neoplasms

ARQ 501

Phase 2

Cancer

ADL5945

Phase 2

Opioid Induced Constipation

Robatumumab

Phase 2

Colorectal Cancer

MK0431, sitagliptin phosphate

Phase 2

Diabetes Mellitus, Type II

M5717

Phase 2

Acute Malaria

MK0812

Phase 2

Arthritis, Rheumatoid

Vibostolimab

Phase 2

Melanoma

MK0493

Phase 2

Obesity

Selumetinib capsule formulation

Phase 2

Neurofibromatosis Type 1

INS37217 Nasal Spray

Phase 2

Perennial Allergic Rhinitis

MK0777

Phase 2

Generalized Anxiety Disorder

Uprifosbuvir

Phase 2

Hepatitis C

Pneumococcal Conjugate Vaccine (V114)

Phase 2

Pneumococcal Infections

V114 Aluminum-adjuvanted

Phase 2

Pneumococcal Infections

Vibostolimab/Pembrolizumab

Phase 2

Carcinoma, Renal Cell

MK-3120

Phase 2

Urothelial Carcinoma

Navarixin

Phase 2

Solid Tumors

Daptomycin for Injection

Phase 2

Bacteremia

UFOX + Cetuximab

Phase 2

Previously Untreated Metastatic Colorectal Cancer

Raludotatug Deruxtecan (R-DXd)

Phase 2

Gastrointestinal Cancer

Tepotinib

Phase 2

Non-small Cell Lung Cancer

TMC647055

Phase 2

Chronic Hepatitis C Virus

MK-3795

Phase 2

VHL Gene Mutation

V114 Lot 1

Phase 2

Pneumococcal Infections

adavosertib

Phase 2

Ovarian Cancer

MK0249

Phase 2

Attention-Deficit/Hyperactivity Disorder (ADHD)

MK-8435 (Org 25935)

Phase 2

Schizophrenia

MK-6096

Phase 2

Migraine

Pembrolizumab/vibostolimab coformulation

Phase 2

Bladder Cancer

irinotecan hydrochloride

Phase 2

Metastatic Colorectal Cancer

MK-0941

Phase 2

Type 2 Diabetes Mellitus

IDX719

Phase 2

Hepatitis C, Chronic

Ritonavir (RTV)

Phase 2

Chronic Hepatitis C Virus

MK2295

Phase 2

Pain, Postoperative

Quavonlimab

Phase 2

Advanced Solid Tumors

MK-1167

Phase 2

Alzheimer Disease

SCH 530348

Phase 2

Arterial Obstructive Diseases

Epinastine Nasal Spray

Phase 2

Seasonal Allergic Rhinitis

Merck L-830982

Phase 2

Schizophrenia

MK-4830

Phase 2

Carcinoma, Non-Small-Cell Lung

zoster vaccine live (Oka/Merck)

Phase 2

Shingles

Raludotatug Deruxtecan

Phase 2

Ovarian Cancer Recurrent

Coformulation favezelimab/pembrolizumab

Phase 2

Esophageal Squamous Cell Carcinoma (ESCC)

Fludrocortisone/Fludrocortisone acetate

Phase 2

Malignant Neoplasm

Fosaprepitant

Phase 2

Chemotherapy-induced Nausea and Vomiting

Farnesyl Protein Transferase Inhibitor

Phase 2

Leukemia

ADL5859

Phase 2

Peripheral Neuropathy

MK2461

Phase 2

Neoplasm

MK0991, caspofungin acetate

Phase 2

Aspergillosis

SCH 486757

Phase 2

Cough

Tecemotide (L-BLP25)

Phase 2

Lung Neoplasms

measles, mumps, and rubella virus vaccine live

Phase 2

Measles

AS900672-Enriched 50 microgram (mcg)

Phase 2

Infertility

Dexamethasone/Dexamethasone acetate

Phase 2

Malignant Neoplasm

Cilengitide

Phase 2

Carcinoma, Non-Small-Cell Lung

ecallantide

Phase 2

Bloodloss

Pembrolizumab (neoadjuvant)

Phase 2

Lung Neoplasm Malignant

MK0518

Phase 2

HIV Infections

Megestrol acetate/Medroxyprogesterone acetate

Phase 2

Malignant Neoplasm

ENB003

Phase 2

Cancer

MK-5684

Phase 2

Malignant Neoplasm

Attenuvax

Phase 2

HIV Infections

M5049 low dose

Phase 2

Systemic Lupus Erythematosus

Pegylated Interferon Alfa

Phase 2

Chronic Hepatitis C

KW-3902IV

Phase 2

Heart Failure, Congestive

Favezelimab

Phase 2

Advanced Non-Small Cell Lung Cancer

tildrakizumab

Phase 2

Psoriasis

SCH 900538

Phase 2

Seasonal Allergic Rhinitis

EBR/GZR FDC Tablet

Phase 2

HCV Infection

Mavyret

Phase 2

End Stage Renal Disease

MK0916

Phase 2

Diabetes Mellitus, Type 2

V160

Phase 2

Cytomegalovirus (CMV) Infections

MK-2140 (zilovertamab vedotin)

Phase 2

Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Cabazitaxel

Phase 2

Prostatic Neoplasms, Castration-Resistant

L-dopa

Phase 2

Parkinson Disease

MK0364

Phase 2

Obesity

Single low dose cyclophosphamide

Phase 2

Carcinoma, Non-Small-Cell Lung

MK-8189

Phase 2

Schizophrenia, Acute Episode

Recombinant human growth hormone (r-hGH)

Phase 2

Hypochondroplasia

CyPep-1

Phase 2

Advanced Head and Neck Squamous Cell Carcinoma

Pembrolizumab and Lenvatinib

Phase 2

Hepatocellular Carcinoma

Boserolimab

Phase 2

Small Cell Lung Cancer

2 NRTIs

Phase 2

Human Immunodeficiency Virus (HIV) Infection

PegIFN-2b

Phase 2

HIV Infections

PegIntron (peginterferon alfa-2b)

Phase 2

Hepatitis C, Chronic

Atorvastatin/niacin extended-release

Phase 2

Carotid Atherosclerosis

Rebif

Phase 2

Multiple Sclerosis

MK-0873

Phase 2

Rheumatoid Arthritis

Matuzumab

Phase 2

Esophageal Cancer

V504

Phase 2

Cervical Cancer

imipenem/cilastatin

Phase 2

Urinary Tract Infections

cetuximab, cisplatin

Phase 2

Breast Neoplasm

Interferon beta-1a

Phase 2

Alzheimer's Disease

V114 Medium Dose

Phase 2

Pneumococcal Infections

V181 High-Potency Level

Phase 2

Dengue Disease

cyclophosphamide (CPA)

Phase 2

Rectal Cancer

Biltricide (racemate praziquantel) oral tablets

Phase 2

Schistosomiasis

Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)

Phase 2

Infertility Implantation Failure

SCH 900636

Phase 2

Depressive Disorders

Pegylated Lyposomal Doxorubicin

Phase 2

Breast Neoplasm

EMD 525797

Phase 2

Metastatic Colorectal Cancer

MK0782

Phase 2

Stomach Ulcer

TR701 FA

Phase 2

Major Cutaneous Abscess

Doravirine, Tenofovir, Lamivudine - Blinded

Phase 2

HIV-1

V940

Phase 2

Squamous Non-small Cell Lung Cancer

Efinopegdutide

Phase 2

Metabolic Dysfunction-Associated Steatotic Liver Disease

Cetuximab/avelumab

Phase 2

Head and Neck Squamous Cell Carcinoma (HNSCC)

PRA023 IV

Phase 2

Crohn Disease

Zolinza (vorinostat)

Phase 2

Lymphoma

Metolazone

Phase 2

Heart Failure

PegLiposomal Doxorubicin

Phase 2

Mesenchymal Tumor

ST-067

Phase 2

Cancer

Miransertib

Phase 2

PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)

MK-0893

Phase 2

Diabetes Mellitus, Type 2

GI-101A

Phase 2

Advanced Solid Tumor

ZA

Phase 2

Breast Cancer

L-756423

Phase 2

HIV Infections

timolol/dorzolamide combination

Phase 2

Glaucoma

AO-176

Phase 2

Solid Tumor

Esmeron®

Phase 2

Neuromuscular Blockade

NM283 plus Peg-IFNα-2a

Phase 2

Chronic Hepatitis C

MK-2060

Phase 2

End-Stage Renal Disease

IDX184

Phase 2

Chronic Hepatitis C Infection

Pleconaril

Phase 2

Asthma

KVA12123 - Dose Escalation

Phase 2

Cancer

Gocatamig

Phase 2

Small-Cell Lung Cancer

MK-1200

Phase 2

Advanced Solid Tumors

SCH 727965

Phase 2

Breast Neoplasms

V114-A

Phase 2

Pneumococcal Infections

IFN beta 1a TIW

Phase 2

Multiple Sclerosis

Pegylated Liposomal Doxorubicin

Phase 2

Breast Neoplasm

Lenvatinib Capsules

Phase 2

Hepatocellular Carcinoma

Avastin

Phase 2

High-grade Serous Ovarian Carcinoma

Atacicept

Phase 2

Rheumatoid Arthritis

Vibegron

Phase 2

Urinary Bladder, Overactive

Org 34517

Phase 2

Depression

MK-1029

Phase 2

Asthma

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate

Phase 2

HIV-1 Infection

TERN-701

Phase 2

Chronic Myeloid Leukemia, Chronic Phase

CRS-207

Phase 2

Metastatic Pancreatic Adenocarcinoma

Lenvatinib Oral Product

Phase 2

Merkel Cell Carcinoma

Coformulated favezelimab/pembrolizumab

Phase 2

Metastatic Urothelial Carcinoma

val-mCyd

Phase 2

Chronic Hepatitis C

Radium-223

Phase 2

Prostate Cancer

valopicitabine

Phase 2

Chronic Hepatitis C

MK0677

Phase 2

Alzheimer's Disease

Interferon-beta-1a, 44 microgram

Phase 2

Ulcerative Colitis

MK0991, caspofungin acetate/Duration of Treatment: variable

Phase 2

Candidiasis

Antihistamine

Phase 2

Esophageal Squamous Cell Carcinoma

Oral testosterone undecanoate (Andriol)

Phase 2

Hypogonadism

Dalantercept

Phase 2

Squamous Cell Carcinoma of the Head and Neck

Sugar Pill

Phase 2

Osteoarthritis of the Knee

Vorapaxar

Phase 2

Atherosclerosis

Docetetaxel

Phase 2

Carcinoma, Non-Small-Cell Lung

Pertuzumab

Phase 2

Breast Neoplasms

epinastine

Phase 2

Allergic Rhinitis

MK-8998

Phase 2

Schizophrenia

ATX-MS-1467

Phase 2

Multiple Sclerosis

Dalantercept plus sorafenib

Phase 2

Advanced Adult Hepatocellular Carcinoma

Nelfinavir mesylate

Phase 2

HIV Infections

AR51 (12, 10)

Phase 2

Bacterial Infections; Virus Diseases

EV

Phase 2

Bladder Cancer

diphenhydramine

Phase 2

Carcinoma, Non-Small-Cell Lung

MK-8616

Phase 2

Neuromuscular Blockade

Benznidazole

Phase 2

Chagas Disease

FF-10832

Phase 2

Advanced Urothelial Carcinoma

raltegravir and etravirine

Phase 2

HIV-1 Infection

MK8141

Phase 2

Hypertension

Elbasvir Oral Granules

Phase 2

HCV Infection

MK0822A

Phase 2

Vitamin D Deficiency

MK0633

Phase 2

Atherosclerosis

ATRIPLA^TM

Phase 2

HIV-1

NC318

Phase 2

Advanced Non-small Cell Lung Cancer

TATE and pembrolizumab

Phase 2

Colorectal Cancer; Lung Cancer

MK-2010

Phase 2

Advanced Solid Tumors

Interferon-beta-1a, 66 microgram

Phase 2

Ulcerative Colitis

Histamine H1 Receptor Antagonist

Phase 2

Advanced Solid Tumors

MK-3475 (pembrolizumab)

Phase 2

Ovarian Squamous Cell Carcinoma

Histamine H2 Receptor Antagonist

Phase 2

Advanced Solid Tumors

Grazoprevir Oral Granules

Phase 2

HCV Infection

Doravirine, Tenofovir, Lamivudine - Open-Label

Phase 2

HIV-1

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate -300 MG-300 MG

Phase 2

Hiv

suberoylanilide hydroxamic acid (SAHA, Vorinostat)

Phase 2

Breast Cancer

tamoxifen citrate (Tamoxifen)

Phase 2

Breast Cancer

MK633

Phase 2

Chronic Obstructive Pulmonary Disease (COPD)

Doxorubicin hydrochloride

Phase 2

Breast Neoplasms

INCB024360

Phase 2

Microsatellite-instability (MSI) High Colorectal Cancer (CRC)

r-FSH

Phase 2

Ovarian Stimulation

Enclitide Chloride

Phase 2

Hypercholesterolemia

Pimicotinib

Phase 2

Tenosynovial Giant Cell Tumor

Pembrolizumab/Olaparib

Phase 2

SCLC,Extensive Stage

Neoadjuvant Treatment - mFOLFOX6 & Pembrolizumab

Phase 2

Gastro Esophageal Junction Cancer

Pembrolizumab Injection

Phase 2

Squamous Cell Carcinoma

Interleukin-2

Phase 2

Kidney Cancer

coformulation pembrolizumab/quavonlimab

Phase 2

Small Cell Lung Carcinoma

ATRA

Phase 2

Melanoma

MK-2214

Phase 2

Early Alzheimer's Disease

Pembrolizumab & ADG106 (Phase Ib)

Phase 2

Advanced Solid Tumor

OBP-301

Phase 2

Esophageal Adenocarcinoma

Phase Ia dose-escalation part of FB849 Monotherapy

Phase 2

Advanced Solid Tumor

Dabrafenib

Phase 2

Melanoma

MK0524A, niacin (+) laropiprant

Phase 2

Flushing

ridaforolimus (MK8669)

Phase 2

Prostate Cancer

MK0683, vorinostat, Suberoylanilide Hydroxamic Acid (SAHA)

Phase 2

B-cell Lymphoma

Rolapitant Dose 1

Phase 2

Postoperative Nausea and Vomiting

MK0359

Phase 2

Pulmonary Disease, Chronic Obstructive

MK0524

Phase 2

Seasonal Allergies

peginterferon alfa 2b

Phase 2

Hepatitis C, Chronic

MK-7262

Phase 2

Lipoprotein(a)

DF9001

Phase 2

Solid Tumor, Adult

Sargramostim

Phase 2

Biliary Cancer

Taxol

Phase 2

Esophageal Adenocarcinoma

TS-1

Phase 2

Gastric Cancer

Rescue

Phase 2

Type II Diabetes Mellitus

AMG820 and pembrolizumab

Phase 2

Pancreatic Cancer

Recombinant human follicle stimulating hormone (r-hFSH)

Phase 2

Infertility

Regorafenib (Stivarga, BAY73-4506)

Phase 2

Hepatocellular Carcinoma

IRX 2

Phase 2

Breast Cancer

Itraconazole

Phase 2

Chronic Hepatitis C

Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (V501)

Phase 2

HPV Infections

Pegylated Interferon (peg-IFN)

Phase 2

Hepatitis C

Vorinostat and Etoposide

Phase 2

Solid Tumors

Ifinatamab Deruxtecan (I-DXd)

Phase 2

Small Cell Lung Cancer

Ruzasvir

Phase 2

Hepatitis C

Letermovir oral granules

Phase 2

Cytomegalovirus (CMV) Infection

Raltegravir Film-coated Tablet

Phase 2

HIV Infection

teicoplanin

Phase 2

Osteomyelitis

SCH 900271

Phase 2

Primary Hypercholesterolemia

SCH 900518

Phase 2

Hepatitis C, Chronic

MK5757

Phase 2

Schizophrenia

Samatasvir

Phase 2

Chronic Hepatitis C Virus

Ulevostinag

Phase 2

Head and Neck Squamous Cell Carcinoma (HNSCC)

ARQ 501 in combination with gemcitabine

Phase 2

Pancreatic Cancer

V205C, measles, mumps, and rubella virus vaccine live

Phase 2

Measles

medroxyprogesterone acetate tablets OR megestrol acetate

Phase 2

Endometrial Cancer

Islatravir

Phase 2

HIV-1 Infection

RSV A Memphis 37b

Phase 2

Respiratory Syncytial Virus

SCH 619734

Phase 2

Cough

ADL5747

Phase 2

Osteoarthritis of the Knee

TR-701

Phase 2

Skin Diseases, Infectious

MK3207

Phase 2

Migraine

Grazoprevir (GZR)

Phase 2

Hepatitis C Virus

I-DXd

Phase 2

Esophageal Squamous Cell Carcinoma

SCH 56592

Phase 2

Onychomycosis

Grazoprevir/Elbasvir FDC

Phase 2

Hepatitis C

MK-5442

Phase 2

Osteoporosis

Caspofungin

Phase 2

Candidiasis, Esophageal

SCH 497079

Phase 2

Obesity

tretinoin

Phase 2

Acute Myeloid Leukemia

MK-0482

Phase 2

Carcinoma, Non-Small-Cell Lung

EBC

Phase 2

Colorectal Cancer

Guadecitabine

Phase 2

Recurrent Fallopian Tube Carcinoma

FLX475 (tivumecirnon)

Phase 2

Advanced Cancer

MK0736

Phase 2

Hypertension

FLX475

Phase 2

Gastric Cancer

Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 20/40/40/20

Phase 2

Papillomavirus Infections

MK0686

Phase 2

Pain, Postoperative

MK-6213

Phase 2

Hypercholesterolemia

VigantOL oil plus interferon beta-1a (Rebif)

Phase 2

Relapsing-Remitting Multiple Sclerosis

Vicriviroc maleate

Phase 2

HIV

MK-8690

Phase 2

Colitis Ulcerative

MK0429

Phase 2

Post-Menopausal Osteoporosis

Letermovir Pill

Phase 2

CMV

Pyronaridine

Phase 2

Malaria Infection

MK-0634

Phase 2

Urinary Incontinence

ridaforolimus + dalotuzumab

Phase 2

Breast Cancer

rolofyline

Phase 2

Congestive Heart Failure

Posaconazole IV

Phase 2

Invasive Aspergillosis

r-hFSH

Phase 2

Infertility

MK0639, indinavir sulfate

Phase 2

HIV Infections

PR51 (3, 10)

Phase 2

Bacterial Infections; Virus Diseases

carboplatin AUC of 6, paclitaxel, and pembrolizumab, i.v. on day 1

Phase 2

Squamous Cell Carcinoma of Larynx

Methotrexate 1 GM Injection

Phase 2

Gestational Trophoblastic Neoplasias (GTN)

TEW-7197

Phase 2

Metastatic Colorectal Cancer

M9140

Phase 2

Solid Tumors

Imprime PGG

Phase 2

Malignant Neoplasm of Breast

Mirdametinib

Phase 2

Central Nervous System Tumors

Crinone

Phase 2

Postmenopausal Endometrium

Posaconazole PFS

Phase 2

Invasive Fungal Infection

Bintrafusp Alfa

Phase 2

Nasopharyngeal Carcinoma

Pembrolizumab (Keytruda)

Phase 2

Thyroid Cancer

Axatilimab

Phase 2

TNBC - Triple-Negative Breast Cancer

Alendronate

Phase 2

Osteoporosis

Nirogacestat

Phase 2

Tumor

D-1553 in combination with Drug: pembrolizumab, Drug:KEYTRUDA®, Drug: cetuximab, Drug: other

Phase 2

Solid Tumor, Adult

Adjuvant Treatment - mFOLFOX & Pembrolizumab

Phase 2

Gastro Esophageal Junction Cancer

MK-3475 (adjuvant)

Phase 2

Cancer of Head and Neck

mRNA-4157

Phase 2

Melanoma

5-hydroxytryptamine 3 antagonist

Phase 2

Chemotherapy-induced Nausea and Vomiting

Boceprevir, Peg-interferon alfa 2b and Ribavirin

Phase 2

HCV Coinfection

Peg-Interferon α-2b or Peg-Interferon α-2a

Phase 2

HCV Infection

ATG-022

Phase 2

Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

ART Intensification

Phase 2

HIV-1 Infection

Allogeneic cytomegalovirus-specific T cells

Phase 2

Glioblastoma Multiforme

RPL554 Suspension

Phase 2

COPD

pembrolizumab KEYTRUDA®

Phase 2

Advanced Solid Tumor

MK-4208

Phase 2

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Carboplatin/Paclitaxel

Phase 2

Urologic Neoplasms

Bavituximab

Phase 2

Hepatocellular Carcinoma

Vorinostat, Lenalinomide and Dexamethasone

Phase 2

Multiple Myeloma

Talimogene Laherparepvec

Phase 2

Hepatocellular Carcinoma

STK-012

Phase 2

Advanced Solid Tumor

CPA

Phase 2

Relapsed Diffuse Large B-cell Lymphoma

Imipenem/Cilastatin/Relebactam

Phase 2

Hematopoietic and Lymphoid Cell Neoplasm

Posaconazole tablet

Phase 2

Invasive Aspergillosis

ISA101b

Phase 2

HPV-Related Squamous Cell Carcinoma

ADV/HSV-tk

Phase 2

Metastatic Non-small Cell Lung Cancer

Testosterone Enanthate

Phase 2

Male Hypogonadism

BET Bromodomain Inhibitor ZEN-3694

Phase 2

Castration-Resistant Prostate Carcinoma

olaparibp, embro

Phase 2

Ovarian Cancer

aprepitant, ondansetron, dexamethasone

Phase 2

Nausea

azacytidine

Phase 2

Lymphoma

galinpepimut-S

Phase 2

Acute Myelogenous Leukemia

Neoadjuvant Pembrolizumab

Phase 2

Breast Cancer

Entereg

Phase 2

Laparoscopic Colonic Resection

D-1553

Phase 2

Solid Tumor, Adult

Bilastine

Phase 2

Seasonal Allergic Rhinitis

Q901

Phase 2

Advanced Cancer

5HT3

Phase 2

Chemotherapy-Induced Nausea and Vomiting

FOLFIRI + Cetuximab

Phase 2

Metastatic Colorectal Cancer

GVAX Pancreatic Cancer Vaccine

Phase 2

Pancreatic Cancer

Lenvatinib Mesylate

Phase 2

Kidney Cancer

Polatuzumab vedotin

Phase 2

Lymphoma, Large B-Cell, Diffuse

IMGN853

Phase 2

Endometrial Cancer

GAd-209-FSP low dose

Phase 2

Solid Tumor, Adult

Peptide Receptor Radionuclide Therapy (PRRT) using 177Lu-DOTA0-Tyr3-Octreotate

Phase 2

Metastatic Malignant Neoplasm in the Liver

Vinblastine

Phase 2

Classical Hodgkin Lymphoma

Defactinib

Phase 2

Resectable Pancreatic Ductal Adenocarcinoma (PDAC)

ARX201

Phase 2

Growth Hormone Deficiency

Background ART Regimen

Phase 2

HIV Infections

r-hLH

Phase 2

Infertility

Obinutuzumab/Intravenous

Phase 2

Cancer

V114 High Dose

Phase 2

Pneumococcal Infections

V114 High Dose with Alternative Carrier Protein

Phase 2

Pneumococcal Infections

ACE-536

Phase 2

Beta-Thalassemia

Pembrolizuma

Phase 2

Metastatic Breast Cancer

Vorinostat Velcade Dexamethasone

Phase 2

Multiple Myeloma

Pembrolizumab with All-Trans Retinoic Acid

Phase 2

Stage IV Melanoma

Elpipodect

Phase 2

Schizophrenia

ABL103

Phase 2

Solid Tumors

CXA-101/tazobactam and metronidazole

Phase 2

Complicated Intra-abdominal Infection

modifiedFOLFOX6 + Cetuximab

Phase 2

Metastatic Colorectal Cancer

pembrolizumab, gemcitabine and cisplatin

Phase 2

Bladder Cancer

R-CHOP Protocol

Phase 2

B Cell Lymphoma

Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 40/40/40/40

Phase 2

Papillomavirus Infections

Pembrolizumab in

Phase 2

Metastatic Breast Cancer

IO102-103

Phase 2

Head and Neck Squamous Cell Carcinoma

Autologous dendritic cells

Phase 2

Follicular Lymphoma

Raltegravir Chewable Tablet

Phase 2

HIV Infection

darunavir/ritonavir

Phase 2

HIV Infections

V114 Lot 2

Phase 2

Pneumococcal Infections

M7824

Phase 2

Carcinoma, Non-Small-Cell Lung

Other Anti-Retroviral Therapy

Phase 2

HIV Infection

MK-3475 (neoadjuvant)

Phase 2

Cancer of Head and Neck

Bemcentinib

Phase 2

Lung Cancer Metastatic

Ulonivirine

Phase 2

HIV-1 Infection

Optimized background regimen

Phase 2

HIV Infections

indacaterol maleate/mometasone furoate

Phase 2

Asthma

etravirine

Phase 2

HIV Infections

open-label ridaforolimus (MK8669)

Phase 2

Prostate Cancer

PegIntron (PEG)

Phase 2

Chronic Hepatitis C

Atovaquone-Proguanil

Phase 2

Malaria Infection

Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 80/80/40/80

Phase 2

Papillomavirus Infections

Mocaciclib (Q901)

Phase 2

Advanced Cancer

V114 Medium Dose with Alternative Carrier Protein

Phase 2

Pneumococcal Infections

Poly-ICLC

Phase 2

Metastatic Colon Cancer

Pegylated Interferon alpha 2b

Phase 2

HIV-1 Infection

UFT

Phase 2

Metastatic Colorectal Cancer

Vinblastine Sulfate

Phase 2

Stage II Bladder Cancer AJCC v8

DPX-Survivac

Phase 2

Relapsed Diffuse Large B-cell Lymphoma

Bacillus Calmette-Guérin (BCG)

Phase 2

Bladder Cancer

HIF-2alpha Inhibitor PT2385

Phase 2

Recurrent Glioblastoma

pTVG-HP

Phase 2

Castration-resistant Prostate Cancer

emtricitabine/tenofovir disoproxil fumarate/raltegravir

Phase 2

HIV-2 Infection

L19TNF

Phase 2

Melanoma Stage III

GX-188E

Phase 2

Cervical Cancer

GSK2636771

Phase 2

Melanoma and Other Malignant Neoplasms of Skin

Human Papillomavirus vaccine

Phase 2

Cervical High Grade Squamous Intraepithelial Lesion

Tinodasertib

Phase 2

Metastatic Colorectal Cancer

Aprepitant/Ramosetron/Dexamethasone

Phase 2

Chemotherapy-Induced Nausea and Vomiting

Zepatier

Phase 2

End Stage Renal Disease

Prednisone or prednisolone

Phase 2

Metastatic Castration-resistant Prostate Cancer

Sitagliptin + Metformin

Phase 2

Pre-diabetes

ACP-196 in combination with pembrolizumab

Phase 2

Metastatic Urothelial Carcinoma

Cefepime

Phase 2

Other Infectious Diseases

Azithromycin ophthalmic

Phase 2

Blepharitis

129Xe Hyperpolarized

Phase 2

Pulmonary Hypertension

L19IL2

Phase 2

Melanoma Stage III

Pegzilarginase

Phase 2

Small-cell Lung Cancer

Spevatamig (PT886)

Phase 2

Gastric or Gastroesophageal Junction Adenocarcinoma

MK-1775 and carboplatin

Phase 2

Epithelial Ovarian Cancer

EIDD-2801

Phase 2

SARS-CoV 2

Pembrolizumab/Intravenous

Phase 2

Metastatic Uveal Melanoma

Gemox, Cetuximab

Phase 2

Advanced Biliary Cancer

Encorafenib Oral Capsule + Cetuximab

Phase 2

Colorectal Cancer

cetuximab, cisplatin, capecitabine

Phase 2

Gastric Cancer

Epclusa

Phase 2

Lung Diseases

acetominophen

Phase 2

Migraine

FLOT

Phase 2

Esophagogastric Adenocarcinoma

Afatinib

Phase 2

Carcinoma, Non-Small-Cell Lung

Hyperpolarized 13C-Pyruvate

Phase 2

Neuroendocrine Tumors

Cyklokapron(R)

Phase 2

Bloodloss

IMG-7289

Phase 2

Thrombocythemia, Essential

cis/carboplatin and etoposide

Phase 2

Small Cell Lung Cancer (SCLC)

Leucovorin (LV) or levoleucovorin

Phase 2

Colorectal Cancer

Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV∆G-ZEBOV-GP)

Phase 2

Ebola Virus Disease

PR51 (6, 10)

Phase 2

Bacterial Infections; Virus Diseases

GX-I7

Phase 2

Triple Negative Breast Cancer

PR51 (6, 15)

Phase 2

Bacterial Infections; Virus Diseases

L-377202

Phase 2

Hormone Refractory Prostate Cancer

Pembrolizumab(KEYTRUDA®)

Phase 2

Triple Negative Breast Cancer

pembrolizumab (KEYTRUDA®)

Phase 2

Advanced Solid Tumors

MK-0646

Phase 2

Neuroendocrine Tumors

Ibutamoren Mesylate (MK-0677)

Phase 2

Fibromyalgia

Pembrolizumab, Cetuximab

Phase 2

HNSCC

TILT-123

Phase 2

Platinum-refractory Ovarian Carcinoma

KEYTRUDA® (pembrolizumab)

Phase 2

Solid Tumor, Adult

anti-IGF-1R recombinant monoclonal antibody MK-0646

Phase 2

Lung Cancer

Pembrolizumab IV infusion Q3W, with daily oral Olaparib

Phase 2

Relapsed Peripheral T-Cell Lymphoma

Cisplatin/Carboplatin; 5FU

Phase 2

Head and Neck Cancer

Other Parkinson's Disease treatments

Phase 2

Parkinson Disease

Abraxane

Phase 2

Non-small Cell Lung Cancer

Cetuximab (Erbitux)

Phase 2

Cancer

FOLFOX-4+cetuximab

Phase 2

Colorectal Cancer

Capecitabine/5-FU

Phase 2

Colorectal Cancer

Arm B Pemetrexed, Cisplatin and MK-0646

Phase 2

Non Small Cell Lung Cancer

quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine or nonavalent human papillomavirus vaccine (HPV 6, 11, 16, 18, 31, 33, 45, 52, 58)

Phase 2

Cancer Survivor

Nesuparib

Phase 2

Endometrial Cancer

Odetiglucan

Phase 2

Colorectal Adenocarcinoma Metastatic in the Liver

Emtricitabine (FTC)/Tenofovir Disoproxil (TDF)

Phase 2

Primary Biliary Cholangitis

pTVG-AR

Phase 2

Castration-resistant Prostate Cancer

V114 Non-adjuvanted

Phase 2

Pneumococcal Infections

rVSVΔG-ZEBOV-GP, V920

Phase 2

Ebola Virus Disease

Ataluren + Pembrolizumab

Phase 2

Colorectal Cancer

cancer

4 drugs in this indication

Pneumococcal Infections

3 drugs in this indication

breast cancer

2 drugs in this indication

Non Small Cell Lung Cancer

2 drugs in this indication

Melanoma

2 drugs in this indication

Recurrent Mantle Cell Lymphoma

2 drugs in this indication

HPV vaccine

1 drug in this indication

muscle invasive bladder cancer

1 drug in this indication

Muscle-invasive bladder cancer (MIBC), neoadjuvant and adjuvant treatment

1 drug in this indication

Melanoma Stage IV

1 drug in this indication

dMMR endometrial cancer

1 drug in this indication

Ebola

1 drug in this indication

oncology

1 drug in this indication

first-line treatment (specific indication not stated)

1 drug in this indication

cholesterol

1 drug in this indication

to reduce LDL-C in adults with hypercholesterolemia

1 drug in this indication

dMMR advanced or recurrent endometrial cancer

1 drug in this indication

cardiovascular disease

1 drug in this indication

Hypercholesterolemia (high levels of bad cholesterol)

1 drug in this indication

resectable muscle-invasive bladder cancer (MIBC)

1 drug in this indication

Hepatitis C, Chronic

1 drug in this indication

Dyslipidemia

1 drug in this indication

hidradenitis suppurativa

1 drug in this indication

cholesterol-lowering

1 drug in this indication

PCSK9 inhibitor for LDL-C and Lp(a) lowering

1 drug in this indication

Hepatitis C

1 drug in this indication

PANCREAS

1 drug in this indication

HIV PrEP

1 drug in this indication

Small Cell Lung Cancer

1 drug in this indication

kidney cancer

1 drug in this indication

Diabetic Macular Edema (DME)

1 drug in this indication

advanced renal cell carcinoma

1 drug in this indication

diabetic macular edema

1 drug in this indication

eye disease

1 drug in this indication

Non-small Cell Lung Cancer, NSCLC

1 drug in this indication

stage two or three bowel cancer

1 drug in this indication

ovarian cancer

1 drug in this indication

Advanced Solid Tumor

1 drug in this indication

Muscle Relaxation

1 drug in this indication

Colorectal Cancer

1 drug in this indication

Cisplatin-eligible muscle-invasive bladder cancer (MIBC)

1 drug in this indication

Metastatic tumor mutational burden-high (TMB-H) solid tumors

1 drug in this indication

metastatic neuroendocrine prostate cancer (NEPC)

1 drug in this indication

melanoma (personalized cancer vaccine)

1 drug in this indication

Perioperative treatment of resectable muscle-invasive bladder cancer (MIBC) in adults, in combination with Padcev

1 drug in this indication

cancer (wide set of oncology indications)

1 drug in this indication

Malignant Neoplasms of Male Genital Organs

1 drug in this indication

In combination with paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

1 drug in this indication

MASH (metabolic dysfunction-associated steatohepatitis)

1 drug in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Frequently asked questions

What is in MERCK's drug pipeline?→

CatalystAlert tracks 953 drug candidates in MERCK's (MRK) pipeline across Phase 3, Phase 2, Approved. Its lead program is sac-TMT (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is MERCK's next FDA catalyst?→

MERCK's (MRK) next tracked catalyst is a PDUFA date expected Apr 22, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track MRK biotech catalysts?→

Add MRK to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MERCK's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply